Order Article Reprints

Wu L, Chen J, Cai R, Wang X, Liu Y, Zheng Q, Li L. Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia. Cancers. 2023; 15(10):2767. https://doi.org/10.3390/cancers15102767

Wu, Lijuan, Junchao Chen, Ruifen Cai, Xinrui Wang, Yixiao Liu, Qingshan Zheng, and Lujin Li. 2023. "Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia" Cancers 15, no. 10: 2767. https://doi.org/10.3390/cancers15102767

Wu, L., Chen, J., Cai, R., Wang, X., Liu, Y., Zheng, Q., & Li, L. (2023). Difference in Efficacy and Safety of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Containing 4-1BB and CD28 Co-Stimulatory Domains for B-Cell Acute Lymphoblastic Leukemia. Cancers, 15(10), 2767. https://doi.org/10.3390/cancers15102767